Heterogeneously dense breast tissue is not dangerous on its own. It’s a normal variation in breast composition found in about 4 out of every 10 women. Having this tissue type does slightly increase your risk of developing breast cancer compared to someone with average density, but the increase is modest, and density is just one factor among many that shape your overall risk.
What Heterogeneously Dense Means
Breast tissue is a mix of fatty tissue and fibroglandular tissue (the milk-producing glands and the connective tissue that supports them). When a radiologist reads your mammogram, they classify your breast density into one of four categories: almost entirely fatty, scattered areas of fibroglandular density, heterogeneously dense, or extremely dense. “Heterogeneously dense” is the third category, meaning most of your breast tissue is dense with some areas of fat mixed in.
The first two categories are considered “not dense.” The last two, including heterogeneously dense, are considered “dense.” This distinction matters because it affects both how well mammograms work and how your cancer risk is calculated.
How Much It Raises Cancer Risk
The risk increase from heterogeneously dense tissue is real but small. Compared to women with scattered fibroglandular density (the most common pattern over age 50), women with heterogeneously dense breasts have roughly 1.2 to 1.5 times the risk of developing breast cancer. For context, extremely dense tissue carries about twice the risk. Neither category means cancer is likely, just that the baseline probability is somewhat higher.
To put those numbers in perspective: if a woman with average density has about a 12% lifetime risk of breast cancer, a 1.2 to 1.5 fold increase would bring that to roughly 14% to 18%. That’s a meaningful difference for population-level statistics, but it doesn’t mean any individual woman should expect a diagnosis. Many other factors, including age, family history, whether you’ve had previous breast biopsies, and genetic variations, contribute to your personal risk. Some clinical risk calculators now fold breast density into their formulas alongside these other factors to give a more complete picture.
The Bigger Concern: Masking on Mammograms
For many women with heterogeneously dense breasts, the more immediate concern isn’t the cancer risk itself but the fact that dense tissue makes cancers harder to spot. On a mammogram, both dense tissue and tumors appear white, so a small mass can blend into the surrounding tissue. This is called the masking effect.
Mammography catches about 69% of cancers in women with heterogeneously dense breasts. That’s noticeably lower than the 88% detection rate in women with mostly fatty tissue, though better than the 62% rate for extremely dense breasts. In practical terms, roughly 3 out of 10 cancers in heterogeneously dense breasts could be missed by mammography alone.
This is why, since September 2024, the FDA requires mammography facilities to notify you directly if your tissue is dense. The notification will tell you that dense tissue makes it harder to find breast cancer on a mammogram and raises the risk of developing it, and it will recommend talking with your healthcare provider about whether additional imaging makes sense for you.
Whether You Need Additional Screening
This is where things get less straightforward. The U.S. Preventive Services Task Force has stated there is currently insufficient evidence to recommend for or against supplemental screening with ultrasound or MRI for women whose only additional risk factor is dense tissue. The task force has called for more research, acknowledging this is an important gap in the evidence.
That said, two additional imaging options exist. Breast ultrasound uses sound waves to create images and can detect some cancers that mammograms miss in dense tissue. Breast MRI is more sensitive still but is typically reserved for women at higher overall risk (not density alone). Your provider may recommend one of these if you have other risk factors layered on top of dense tissue, such as a strong family history, a known genetic mutation, or a history of atypical biopsy results.
The key point is that heterogeneously dense tissue alone doesn’t automatically mean you need extra tests. It means density should be considered alongside everything else in your medical history. If your only risk factor is density and you have no family history or other concerns, routine mammography on the recommended schedule may be sufficient. If you do have additional risk factors, supplemental imaging becomes a more serious conversation.
What You Can Actually Do
You can’t change your breast density. It’s largely determined by genetics, though it tends to decrease somewhat with age and can be influenced by hormonal factors like menopause and hormone replacement therapy. What you can do is make sure density is part of the conversation when you and your provider discuss screening.
Start by confirming your density category. Your mammogram report now includes this information, and facilities are required to provide it in plain language. If you’re classified as heterogeneously dense, ask your provider to assess your overall lifetime risk using a model that actually incorporates density. Not all risk calculators do. The Gail model, one of the most commonly used, does not include breast density. More comprehensive tools like the Tyrer-Cuzick model or the Breast Cancer Surveillance Consortium model do factor it in and give a more accurate estimate.
If your calculated lifetime risk is 20% or higher, most guidelines support adding MRI screening to your routine. If it falls below that threshold, the decision about supplemental imaging is more nuanced and depends on your comfort level, your provider’s judgment, and what other risk factors are present. The bottom line: heterogeneously dense tissue is common, carries a modestly elevated risk, and is most significant because it can hide problems on standard mammograms. Knowing your density gives you the information to plan screening that fits your actual risk profile.